These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20586717)
1. Synthesis and preliminary screening of novel tryptamines as 5-HT4 receptor ligands. Hanna-Elias A; Manallack DT; Berque-Bestel I; Irving HR; Coupar IM; Iskander MN Curr Med Chem; 2010; 17(25):2775-87. PubMed ID: 20586717 [TBL] [Abstract][Full Text] [Related]
2. The use of tripeptides for lead discovery of 5-HT4 receptor ligands. Hanna-Elias A; Thompson PE; Manallack DT; Irving HR; Coupar IM; Berque-Bestel I; Iskander MN Protein Pept Lett; 2009; 16(7):805-9. PubMed ID: 19601910 [TBL] [Abstract][Full Text] [Related]
3. Discovery and pharmacological profile of new hydrophilic 5-HT(4) receptor antagonists. Brudeli B; Navaratnarajah M; Andressen KW; Manfra O; Moltzau LR; Nilsen NO; Levy FO; Klaveness J Bioorg Med Chem Lett; 2014 Sep; 24(18):4598-4602. PubMed ID: 25149506 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists. Brudeli B; Moltzau LR; Andressen KW; Krobert KA; Klaveness J; Levy FO Bioorg Med Chem; 2010 Dec; 18(24):8600-13. PubMed ID: 21075638 [TBL] [Abstract][Full Text] [Related]
5. Selectivity of sterically fixed tryptamine and 5-methoxytryptamine derivatives for serotonin receptor subtypes, II: Structure-activity relationships and in vitro pharmacology of N-alkyl- and N,N-dialkyl-3- indolylbicyclo-[2.2.1]-heptane-2-amines. Elz S; Zimmermann H; Rehse K Arch Pharm (Weinheim); 1993 Nov; 326(11):893-9. PubMed ID: 8274071 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and preliminary screening of novel indole-3-methanamines as 5-HT4 receptor ligands. Hanna-Elias A; Manallack DT; Berque-Bestel I; Irving HR; Coupar IM; Iskander MN Eur J Med Chem; 2009 Jul; 44(7):2952-9. PubMed ID: 19223092 [TBL] [Abstract][Full Text] [Related]
7. Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Villalón CM; den Boer MO; Heiligers JP; Saxena PR Br J Pharmacol; 1991 Jan; 102(1):107-12. PubMed ID: 2043916 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers. Dubost E; Dumas N; Fossey C; Magnelli R; Butt-Gueulle S; Ballandonne C; Caignard DH; Dulin F; Sopkova de-Oliveira Santos J; Millet P; Charnay Y; Rault S; Cailly T; Fabis F J Med Chem; 2012 Nov; 55(22):9693-707. PubMed ID: 23102207 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the pharmacological properties of 5-methoxyindole derivatives at 5-HT4 receptors. Coupar IM; Irving HR; Manallack DT; Tan YY; Ayad F; Iulio JD; Tochon-Danguy N; Iskander MN J Pharm Pharmacol; 2012 Aug; 64(8):1099-106. PubMed ID: 22775213 [TBL] [Abstract][Full Text] [Related]
10. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years. Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and analgesic activity of N,N'-dicarbonyltryptamines. Dongmei H; Chao W; Ming Z; Shiqi P Prep Biochem Biotechnol; 2000 Aug; 30(3):231-40. PubMed ID: 10919562 [TBL] [Abstract][Full Text] [Related]
12. Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities. Fontenelle CQ; Wang Z; Fossey C; Cailly T; Linclau B; Fabis F Bioorg Med Chem; 2013 Dec; 21(23):7529-38. PubMed ID: 24128816 [TBL] [Abstract][Full Text] [Related]
13. N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity. Shulgin AT; Carter MF Commun Psychopharmacol; 1980; 4(5):363-9. PubMed ID: 6949674 [No Abstract] [Full Text] [Related]
14. 5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines. Toro-Sazo M; Brea J; Loza MI; Cimadevila M; Cassels BK PLoS One; 2019; 14(1):e0209804. PubMed ID: 30629611 [TBL] [Abstract][Full Text] [Related]
15. N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues. Nichols DE; Sassano MF; Halberstadt AL; Klein LM; Brandt SD; Elliott SP; Fiedler WJ ACS Chem Neurosci; 2015 Jul; 6(7):1165-75. PubMed ID: 25547199 [TBL] [Abstract][Full Text] [Related]
16. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361 [TBL] [Abstract][Full Text] [Related]